Workflow
Anavex Life Sciences (AVXL)
icon
Search documents
Anavex Life Sciences (AVXL) - 2020 Q2 - Quarterly Report
2020-05-07 20:32
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____to _____ Commission File Number: 001-37606 ANAVEX LIFE SCIENCES CORP. (Exact name of registrant as specified in its charter) Nevada 98-0608404 (IRSEmployer ...
Anavex Life Sciences (AVXL) - 2020 Q1 - Earnings Call Transcript
2020-02-07 00:16
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2020 Earnings Conference Call February 6, 2020 4:30 PM ET Company Participants Clint Tomlinson – Investor Relations Christopher Missling – President and Chief Executive Officer Sandra Boenisch – Principal Financial Officer Conference Call Participants Edward Marks – H. C. Wainwright Yun Zhong – Janney Tom Bishop – BI Research Operator Good afternoon. My name is Anna, and I will be your conference operator today. Welcome to the Anavex Life Sciences to announce Fisc ...
Anavex Life Sciences (AVXL) - 2020 Q1 - Quarterly Report
2020-02-06 22:24
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 31, 2019 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____to _____ Commission File Number: 001-37606 ANAVEX LIFE SCIENCES CORP. (Exact name of registrant as specified in its charter) Nevada 98-0608404 (Stat ...
Anavex Life Sciences (AVXL) - 2019 Q4 - Earnings Call Transcript
2019-12-16 23:20
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q4 2019 Results Earnings Conference Call December 16, 2019 4:30 PM ET Company Participants Clint Tomlinson - Investor Relations Christopher Missling - President and Chief Executive Officer Sandra Boenisch - Principal Financial Officer Conference Call Participants Edward Marks - H.C. Wainwright Yun Zhong - Janney Operator Good afternoon. My name is Hilda and I will be your conference call operator today. Welcome to the Anavex Life Sciences to announce Fiscal 2019 Four ...
Anavex Life Sciences (AVXL) - 2019 Q4 - Annual Report
2019-12-16 22:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2019 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to________________ Commission file number: 001-37606 ANAVEX LIFE SCIENCES CORP. (Exact name of registrant as specified in its charter) Nevada 98-06084 ...
Anavex Life Sciences (AVXL) - 2019 Q3 - Earnings Call Transcript
2019-08-08 01:04
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q3 2019 Earnings Conference Call August 7, 2019 4:30 PM ET Company Participants Clint Tomlinson – Investor Relations Christopher Missling – President and Chief Executive Officer Sandra Boenisch – Principal Financial Officer Conference Call Participants Yun Zhong – Janney Capital Edward Marks – H.C. Wainwright Clayton Berger – Dawson James Tom Bishop – BI Research Anna Vorobyeva – ROTH Capital Operator Welcome to the Anavex Life Sciences Fiscal 2019 Third Quarter Fina ...
Anavex Life Sciences (AVXL) - 2019 Q3 - Quarterly Report
2019-08-07 20:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | --- | --- | --- | |---------------------------------------|------------------|-----------------------------------------------------| | Title of Each Class | Trading Symbol | Name of Each Exchange on Which Registered | | Common Stock Par Value $0.001 | AVXL | NASDAQ Stock Market LLC | FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2 ...
Anavex Life Sciences (AVXL) - 2019 Q2 - Earnings Call Transcript
2019-05-09 05:46
Anavex Life Sciences Corp (NASDAQ:AVXL) Q2 2019 Earnings Conference Call May 8, 2019 4:30 PM ET Company Participants Clint Tomlinson – Investor Relations Christopher Missling – President and Chief Executive Officer Sandra Boenisch – Principal Financial Officer Conference Call Participants Ram Selvaraju – H.C. Wainwright Anna Vorobyeva – Roth Capital Partners Tom Bishop – BI Research Operator Welcome to the Anavex Life Sciences Fiscal 2019 Second Quarter Financial Results and Corporate Update Conference Call ...